Chief Financial Officer
Mon, Apr 1, 2024
Apr 1
4,000 shares @ $58.66
Decreased holdings by -4.10%
Net across this filing: 0.00% (+0 shares)
12th largest trade (out of 84)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 9% above 200-day moving average
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology